文献速递泌尿生殖与妇科肿瘤放疗放疗物理与技术

评估经会阴超声成像作为前列腺癌大分割放疗中靶区追踪的潜在解决方案

Evaluation of transperineal ultrasound imaging as a potential solution for target tracking during hypofractionated radiotherapy for prostate cancer.
PubMed 文献 · Radiat Oncol · 2018-08-20

本研究评估Clarity超声监测系统在前列腺癌大分割放疗中追踪前列腺运动的表现。5例患者共167分次、总计39.7小时的连续经会阴超声成像显示,超声追踪平均将患者最大定位误差降低20%,并将前列腺偏离初始治疗位置超过1毫米的时间占比从37%降至22%。

要点

  • 体模验证显示预测与观测基准点位置吻合在1.1毫米以内。
  • 患者中预测与实际基准点位置吻合度在1.3毫米至3.3毫米之间。
  • 超声追踪平均将最大定位误差降低20%,偏离超过1毫米时间从37%降至22%。

核心结论

  • 实时超声追踪降低了前列腺分次内运动导致的位置不确定性。

研究设计与样本

  • 5例前列腺患者在每日治疗期间接受连续经会阴超声成像,共167分次、总计39.7小时。
  • 通过千伏图像估计前列腺内植入基准点的初始绝对三维位置,并将治疗期间采集的兆伏图像中基准点位置与基于Clarity三维追踪的预测位置进行比较。
  • 在体模验证研究中评估比较结果的不确定性。

主要发现

  • 体模验证显示预测与观测基准点位置吻合在1.1毫米以内。
  • 患者中预测与实际基准点位置吻合度在1.3毫米至3.3毫米之间。
  • 超声追踪平均将患者最大定位误差降低20%。
  • 运动校正后,前列腺偏离初始治疗位置超过1毫米的时间从占总治疗时间的37%降至22%。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Emerging hypofractionated prostate radiotherapy regimens require solutions for accurate target tracking during beam delivery. The goal of this study is to evaluate the performance of the Clarity ultrasound monitoring system for prostate motion tracking. METHODS: Five prostate patients underwent continuous perineum ultrasound imaging during their daily treatments. Initial absolute 3D positions of fiducials implanted in the prostate were estimated from the KV images. Fiducial positions in MV images acquired during beam delivery were compared with predicted positions based on Clarity 3D tracking. The uncertainty in the comparison results was evaluated in a phantom validation study. RESULTS: Continuous real-time ultrasound motion tracking was recorded in 5 patients and 167 fractions for overall of 39.7 h. Phantom validation of the proposed procedure demonstrated that predicted and observed fiducial positions agree within 1.1 mm. In patients agreement between predicted and actual fiducial positions varied between 1.3 mm and 3.3 mm. On average ultrasound tracking reduced the maximum localization error in patients by 20% on average. With the motion corrected, the duration prostate beyond 1 mm from its initial treatment position can be reduced from 37 to 22% of the total treatment time. CONCLUSION: Real-time ultrasound tracking reduces uncertainty in prostate position due to intra-fractional motion. TRIAL REGISTRATION: IRB Protocol #27372 . Date of registration of trial: 12/17/2013.

来源:Radiat Oncol,查看原文。版权归原作者所有。

引用

  1. Han B, Najafi M, Cooper DT, et al. Evaluation of transperineal ultrasound imaging as a potential solution for target tracking during hypofractionated radiotherapy for prostate cancer. Radiat Oncol. 2018. PMID: 30126434. doi:10.1186/s13014-018-1097-8

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。